148 related articles for article (PubMed ID: 35938573)
1. Immediate possible adverse event rates in infants treated with oral propranolol for infantile haemangiomas at an Australian urban tertiary hospital between 2016 and 2019.
Adams L; Ryan E
Australas J Dermatol; 2022 Nov; 63(4):473-478. PubMed ID: 35938573
[TBL] [Abstract][Full Text] [Related]
2. Interventions for infantile haemangiomas of the skin.
Novoa M; Baselga E; Beltran S; Giraldo L; Shahbaz A; Pardo-Hernandez H; Arevalo-Rodriguez I
Cochrane Database Syst Rev; 2018 Apr; 4(4):CD006545. PubMed ID: 29667726
[TBL] [Abstract][Full Text] [Related]
3. Oral propranolol for the treatment of infantile haemangiomas in Singapore.
Tan JMC; Lim HW; Koh MJ
Singapore Med J; 2021 Mar; 62(3):139-142. PubMed ID: 31989180
[TBL] [Abstract][Full Text] [Related]
4. Propranolol in a case series of 174 patients with complicated infantile haemangioma: indications, safety and future directions.
Hermans DJ; Bauland CG; Zweegers J; van Beynum IM; van der Vleuten CJ
Br J Dermatol; 2013 Apr; 168(4):837-43. PubMed ID: 23278381
[TBL] [Abstract][Full Text] [Related]
5. Oral propranolol administration is effective for infantile hemangioma in late infancy: A retrospective cohort study.
Kridin K; Pam N; Bergman R; Khamaysi Z
Dermatol Ther; 2020 May; 33(3):e13331. PubMed ID: 32216160
[TBL] [Abstract][Full Text] [Related]
6. Propranolol for infantile haemangiomas: single centre experience of 250 cases and proposed therapeutic protocol.
Solman L; Murabit A; Gnarra M; Harper JI; Syed SB; Glover M
Arch Dis Child; 2014 Dec; 99(12):1132-6. PubMed ID: 25123404
[TBL] [Abstract][Full Text] [Related]
7. Effectiveness of propanolol for treatment of infantile haemangioma.
Andersen IG; Rechnitzer C; Charabi B
Dan Med J; 2014 Feb; 61(2):A4776. PubMed ID: 24495884
[TBL] [Abstract][Full Text] [Related]
8. Propranolol was effective in treating cutaneous infantile haemangiomas in Thai children.
Techasatian L; Komwilaisak P; Panombualert S; Uppala R; Jetsrisuparb C
Acta Paediatr; 2016 Jun; 105(6):e257-62. PubMed ID: 26919396
[TBL] [Abstract][Full Text] [Related]
9. Cardiac diagnostics before oral propranolol therapy in infantile hemangioma: retrospective evaluation of 234 infants.
Frongia G; Byeon JO; Arnold R; Mehrabi A; Günther P
World J Pediatr; 2018 Jun; 14(3):254-258. PubMed ID: 29796952
[TBL] [Abstract][Full Text] [Related]
10. Noninferiority and Safety of Nadolol vs Propranolol in Infants With Infantile Hemangioma: A Randomized Clinical Trial.
Pope E; Lara-Corrales I; Sibbald C; Liy-Wong C; Kanigsberg N; Drolet B; Ma J
JAMA Pediatr; 2022 Jan; 176(1):34-41. PubMed ID: 34747977
[TBL] [Abstract][Full Text] [Related]
11. Safety assessment during initiation and maintenance of propranolol therapy for infantile hemangiomas.
Babiak-Choroszczak L; Giżewska-Kacprzak K; Dawid G; Gawrych E; Bagłaj M
Adv Clin Exp Med; 2019 Mar; 28(3):375-384. PubMed ID: 30659785
[TBL] [Abstract][Full Text] [Related]
12. Cutaneous Infantile Haemangiomas with Intracranial and Intraspinal Involvement: A European Multicentre Experience and Review.
Diociaiuti A; Carnevale C; Torres EB; Léauté-Labrèze C; Neri I; Rotunno R; Figà-Talamanca L; El Hachem M
Acta Derm Venereol; 2020 Sep; 100(16):adv00255. PubMed ID: 32735025
[TBL] [Abstract][Full Text] [Related]
13. Is prolonged monitoring necessary? An updated approach to infantile hemangioma treatment with oral propranolol.
Johansen ML; Mahendran G; Lawley LP
Pediatr Dermatol; 2021 Jul; 38(4):800-805. PubMed ID: 34115417
[TBL] [Abstract][Full Text] [Related]
14. Cardiac side effects of propranolol in infants treated for infantile haemangiomas.
Maliqari N; Duka E; Kuneshka L
Cardiol Young; 2023 Dec; 33(12):2616-2620. PubMed ID: 37078179
[TBL] [Abstract][Full Text] [Related]
15. Propranolol therapy for cutaneous infantile haemangiomas initiated safely as a day-case procedure.
McSwiney E; Murray D; Murphy M
Eur J Pediatr; 2014 Jan; 173(1):63-8. PubMed ID: 23933667
[TBL] [Abstract][Full Text] [Related]
16. Propranolol for infantile hemangioma: Evaluating efficacy and predictors of response and rebound growth.
Pam N; Kridin K; Khamaysi Z
Dermatol Ther; 2021 May; 34(3):e14936. PubMed ID: 33704861
[TBL] [Abstract][Full Text] [Related]
17. Nd:YAG and pulsed dye laser therapy in infantile haemangiomas: a retrospective analysis of 271 treated haemangiomas in 149 children.
Hartmann F; Lockmann A; Grönemeyer LL; Haenssle HA; Zutt M; von Fintel H; Kühnle I; Schön MP; Thoms KM
J Eur Acad Dermatol Venereol; 2017 Aug; 31(8):1372-1379. PubMed ID: 27911476
[TBL] [Abstract][Full Text] [Related]
18. Oral Nadolol for Children with Infantile Hemangiomas and Sleep Disturbances with Oral Propranolol.
Bernabeu-Wittel J; Narváez-Moreno B; de la Torre-García JM; Fernández-Pineda I; Domínguez-Cruz JJ; Coserría-Sánchez F; Álvarez-del-Vayo C; Conejo-Mir J
Pediatr Dermatol; 2015; 32(6):853-7. PubMed ID: 26447831
[TBL] [Abstract][Full Text] [Related]
19. Safety profile during initiation of propranolol for treatment of infantile haemangiomas in an ambulatory day-care hospitalization setting.
Fogel I; Ollech A; Zvulunov A; Valdman-Greenshpon Y; Atar Snir V; Friedland R; Lapidoth M; Ben-Amitai D
J Eur Acad Dermatol Venereol; 2018 Nov; 32(11):2004-2009. PubMed ID: 29573481
[TBL] [Abstract][Full Text] [Related]
20. Infantile haemangiomas that failed treatment with propranolol: clinical and histopathological features.
Phillips RJ; Lokmic Z; Crock CM; Penington A
J Paediatr Child Health; 2014 Aug; 50(8):619-25. PubMed ID: 24905852
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]